J-PHARMA
J-Pharma’s mission is to help mankind by creating and developing novel pharmaceuticals based upon a human-genomic approach; an approach where people with specific diseases are treated with novel and selective agents. J-Pharma’s intellectual property (IP) embraces the notion that cell membrane transporters are tightly associated to many diseases. In addition to drug molecules that target specific transporters, J-Pharma has discovered several important drug transporters within the human body t... hat may be used to evaluate and optimize pharmacokinetics of new drug candidates. We believe that J-Pharma’s pipelines will lead to new agents and processes (i.e. diagnostic methods) and will increase the quality of life for an ageing population in industrialized countries. J-Pharma’s overall goal is to contribute globally to the maintenance of human health and improve human welfare through the creation of new drugs.
J-PHARMA
Industry:
Biotechnology Medical Nursing And Residential Care
Founded:
2005-12-26
Address:
Yokohama, Kanagawa, Japan
Country:
Japan
Website Url:
http://www.j-pharma.com
Total Employee:
1+
Status:
Active
Contact:
+81-45-506-1155
Email Addresses:
[email protected]
Total Funding:
4.83 M USD
Technology used in webpage:
Viewport Meta SPF SSL By Default Google Analytics LetsEncrypt Google Tag Manager WordPress Content Delivery Network Font Awesome Apache
Current Employees Featured
Founder
Investors List
F-Prime Capital
F-Prime Capital investment in Series D - J-Pharma
Eight Roads Ventures
Eight Roads Ventures investment in Series D - J-Pharma
KNC Laboratories
KNC Laboratories investment in Series D - J-Pharma
Sansei Capital Investment
Sansei Capital Investment investment in Series D - J-Pharma
Osaka University Venture Capital
Osaka University Venture Capital investment in Series D - J-Pharma
Nippon Venture Capital
Nippon Venture Capital investment in Series D - J-Pharma
MBLVC
MBLVC investment in Series D - J-Pharma
QB Capital
QB Capital investment in Series D - J-Pharma
Ohara Pharmaceutical
Ohara Pharmaceutical investment in Series D - J-Pharma
Spera Pharma
Spera Pharma investment in Series D - J-Pharma
Official Site Inspections
http://www.j-pharma.com
- Host name: yellow-giraffe-877fc30df65672a2.znlc.jp
- IP address: 164.46.119.154
- Location: Japan
- Latitude: 35.69
- Longitude: 139.69
- Timezone: Asia/Tokyo
More informations about "J-Pharma"
Organization and Personnel Changes | ジェイファーマ株式会社
Mar 16, 2021 J-Pharma Co., Ltd. PDF For Print. Yokohama, Japan, March 19, 2021 – J-Pharma Co., Ltd. (“J-Pharma”) has announced the below organization and personnel changes. …See details»
Organization and Personnel Changes - j-pharma.com
Info@j- pharma.com. Organization and Personnel Changes Yokohama, Japan, February 26, 2021 – J-Pharma Co., Ltd. (“J-Pharma”) has announced the below organization and personnel …See details»
J-Pharma - Crunchbase Company Profile & Funding
J-Pharma’s mission is to help mankind by creating and developing novel pharmaceuticals based upon a human-genomic approach; an approach where …See details»
J-Pharma Company Profile | Management and Employees List
J-Pharma Profile and History . We are pleased to inform you that we have raised a total of 1,746 million yen. Newton Biocapital SA Spera Pharma Co., Ltd. Popular Searches. J Pharma.co …See details»
J-Pharma Co., Ltd. - Drug pipelines, Patents, Clinical trials - Synapse
Explore J-Pharma Co., Ltd. with its drug pipeline, therapeutic area, technology platform, 2 clinical trials, 1 news, and 55 literature, Disease Domain:Neoplasms ...See details»
J-Pharma Company Profile 2024: Valuation, Funding
J-Pharma General Information Description. Developer of pharmaceutical drugs designed to target transporters aimed at cancer treatment. The company's drugs include anti-cancer drugs and PET diagnostic agents against LAT1 that are …See details»
Interviews with leading Life Sciences companies: J …
May 26, 2023 J-Pharma is a frontrunner in developing inhibitors of L-type amino acid transporter for treating advanced refractory cancers and autoimmune diseases. Learn more about the Yokohama-based organization in this …See details»
Organization and Personnel Changes 19March2021 - j-pharma.com
Company Name: J-Pharma Co., Ltd. Contact: Tomohiro Yuzawa, Director, Corporate Management Dept. Tel: 045-506-1155 [email protected] Organization and Personnel …See details»
J-Pharma Co., Ltd. | Global Startup Acceleration Program (GSAP) …
Global Startup Acceleration Program (GSAP) Alumnis J-Pharma Co., Ltd. CIC '21 Bio/Healthcare Healthcare Manufacturing Chemistry Biotech Website; From its establishment in 2005 by …See details»
J-Pharma - Funding, Financials, Valuation & Investors - Crunchbase
Venture Round - J-Pharma . 1: obfuscated. obfuscated. Iwagin Jigyo Souzou Capital: Jan 1, 2013: Venture Round - J-Pharma . 1: obfuscated. obfuscated — Investors. Edit Investors Section. …See details»
J Pharma Overview | SignalHire Company Profile
J Pharma is a private company that has been in the industry for 18 years. The company currently specializes in the Pharmaceuticals, Pharmaceuticals areas. The position of the President & …See details»
J-Pharma - Overview, News & Similar companies | ZoomInfo.com
Aug 27, 2020 J-Pharma contact info: Phone number: +81 455061155 Website: www.j-pharma.com What does J-Pharma do? We are pleased to inform you that we have raised a …See details»
Organization and Personnel Changes | ジェイファーマ株式会社
February 26,2021 J-Pharma Co., Ltd. PDF For Print. Yokohama, Japan, February 26, 2021 – J-Pharma Co., Ltd. (“J-Pharma”) has announced the below organization and personnel changes …See details»
J-Pharma Co., Ltd. - BIO International Convention | BIO
J-Pharma is a biotech venture established based on technologies developed at Kyorin University. The company is developing a novel drug by leveraging its intellectual properties related to cell …See details»
J-Pharma - Products, Competitors, Financials, Employees, …
When was J-Pharma founded? J-Pharma was founded in 2005. Where is J-Pharma's headquarters? J-Pharma's headquarters is located at Leading Venture Plaza 1 75-1, …See details»
JPH-034 - Drug Targets, Indications, Patents - Synapse - Patsnap
Dec 26, 2024 JPH-034: a SLC7A5 inhibitors Drug, Initially developed by J-Pharma Co., Ltd., Now, its global highest R&D status is Phase 2, Mechanism: SLC7A5 inhibitors(L-type amino …See details»
J-Pharma
J-Pharma has chosen a "company with Audit and Supervisory Committee" structure to match the scale and nature of our business and to promote efficient management. View More. News …See details»
JPH-101 - Drug Targets, Indications, Patents - Synapse - Patsnap
Nov 21, 2024 JPH-101: a Phosphate-binding proteins modulators Drug, Initially developed by J-Pharma Co., Ltd., Now, its global highest R&D status is Discontinued, Mechanism: Phosphate …See details»
Business | J-Pharma
J-Pharma Co., Ltd. 〒230-0046 Leading Venture Plaza 1 75-1 Onocho, Tsurumi-ku, Yokohama, 230-0046 Japan TEL 045-506-1155 / FAX 045-506-1156See details»